
Sign up to save your podcasts
Or


Welcome to 2025! Join the Stock Club team as we pitch our favorite stocks and industries for 2025.
Emmet jumps into the revolutionary gene-editing technology CRISPR and its potential to reshape biology and medicine.
Anne Marie examines three major brands—Nike, Disney, and Starbucks—whose stock prices have slumped and evaluates their recovery prospects for the year ahead.
Finally, Mike discusses the 'Magnificent Seven' tech giants and the potential impact of their massive AI investments on the market. Tune in to explore these exciting developments and investment opportunities.
Recently, Emmet reinvested two stocks he believes will become 100 baggers in his lifetime. One of which was recently pitched by The Motley Fool’s Bill Mann.
They’re high-risk, high-reward, but are businesses that could be world-changing.
We have an exclusive offer for our podcast listeners, to grab it, email us at [email protected]
Don’t wait.
Become a successful investor by checking out all the content MyWallSt has to offer:
📩 Email us: [email protected]
📚 Learn the fundamentals of investing by downloading our free Learn app: https://bit.ly/3DXPOz7
💻 Keep updated on stock market news by visiting our blog: https://mywallst.com/blog/
🎧 Tune in to our podcast Stock Club to stay updated on weekly news: https://mywallst.com/stock-investment-podcast/
🎉 Follow MyWallSt on social:
🐦 Twitter: @MyWallStHQ
💃 TikTok: @MyWallSt
📸 Instagram: @MyWallSt
🖥️ Facebook: @MyWallSt
👔 LinkedIn: MyWallSt
00:00 Introduction to Groundbreaking Gene Editing Technology
07:59 Deep Dive into CRISPR Technology
18:05 Ethical Concerns and Future of CRISPR
26:06 Nike's Challenges and Opportunities
33:56 Activist Investors Shake Up Disney
42:03 Starbucks' Identity Crisis
48:19 The Magnificent Seven: Tech Giants in 2025
54:45 Amazon's Stock Anomaly and Bezos' Influence
01:01:47 Closing Thoughts and Reflections
Hosted on Acast. See acast.com/privacy for more information.
By MyWallSt4.8
9898 ratings
Welcome to 2025! Join the Stock Club team as we pitch our favorite stocks and industries for 2025.
Emmet jumps into the revolutionary gene-editing technology CRISPR and its potential to reshape biology and medicine.
Anne Marie examines three major brands—Nike, Disney, and Starbucks—whose stock prices have slumped and evaluates their recovery prospects for the year ahead.
Finally, Mike discusses the 'Magnificent Seven' tech giants and the potential impact of their massive AI investments on the market. Tune in to explore these exciting developments and investment opportunities.
Recently, Emmet reinvested two stocks he believes will become 100 baggers in his lifetime. One of which was recently pitched by The Motley Fool’s Bill Mann.
They’re high-risk, high-reward, but are businesses that could be world-changing.
We have an exclusive offer for our podcast listeners, to grab it, email us at [email protected]
Don’t wait.
Become a successful investor by checking out all the content MyWallSt has to offer:
📩 Email us: [email protected]
📚 Learn the fundamentals of investing by downloading our free Learn app: https://bit.ly/3DXPOz7
💻 Keep updated on stock market news by visiting our blog: https://mywallst.com/blog/
🎧 Tune in to our podcast Stock Club to stay updated on weekly news: https://mywallst.com/stock-investment-podcast/
🎉 Follow MyWallSt on social:
🐦 Twitter: @MyWallStHQ
💃 TikTok: @MyWallSt
📸 Instagram: @MyWallSt
🖥️ Facebook: @MyWallSt
👔 LinkedIn: MyWallSt
00:00 Introduction to Groundbreaking Gene Editing Technology
07:59 Deep Dive into CRISPR Technology
18:05 Ethical Concerns and Future of CRISPR
26:06 Nike's Challenges and Opportunities
33:56 Activist Investors Shake Up Disney
42:03 Starbucks' Identity Crisis
48:19 The Magnificent Seven: Tech Giants in 2025
54:45 Amazon's Stock Anomaly and Bezos' Influence
01:01:47 Closing Thoughts and Reflections
Hosted on Acast. See acast.com/privacy for more information.

3,216 Listeners

3,372 Listeners

942 Listeners

523 Listeners

353 Listeners

297 Listeners

946 Listeners

1,419 Listeners

196 Listeners

302 Listeners

916 Listeners

561 Listeners

47 Listeners

63 Listeners

51 Listeners